000 | 01322 a2200373 4500 | ||
---|---|---|---|
005 | 20250513050151.0 | ||
264 | 0 | _c19950329 | |
008 | 199503s 0 0 eng d | ||
022 | _a0033-3158 | ||
024 | 7 |
_a10.1007/BF02244893 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDooley, D J | |
245 | 0 | 0 |
_aDifferential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test. _h[electronic resource] |
260 |
_bPsychopharmacology _c1993 |
||
300 |
_a452-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
650 | 0 | 4 |
_aAnxiety _xdrug therapy |
650 | 0 | 4 |
_aDiazepam _xantagonists & inhibitors |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectroshock |
650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
650 | 0 | 4 |
_aFlumazenil _xpharmacology |
650 | 0 | 4 |
_aIndoles _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeglumine _xanalogs & derivatives |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOndansetron _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Cholecystokinin _xantagonists & inhibitors |
700 | 1 | _aKlamt, I | |
773 | 0 |
_tPsychopharmacology _gvol. 112 _gno. 4 _gp. 452-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02244893 _zAvailable from publisher's website |
999 |
_c7870392 _d7870392 |